Menu
Back to User profile » Dr Olaf Holz
Papers published by Dr Olaf Holz:
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
Pedersen F, Trinkmann F, Abdo M, Kirsten AM, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:487-493
Published Date: 1 March 2021
Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise
Holz O, DeLuca DS, Roepcke S, Illig T, Weinberger KM, Schudt C, Hohlfeld JM
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1-13
Published Date: 6 January 2020
Rating sputum cell quality in clinical trials for asthma and COPD treatment
Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:195-198
Published Date: 8 January 2019
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987
Published Date: 22 March 2017
Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD
Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1393-1402
Published Date: 21 July 2015
Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2
Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI
Journal of Inflammation Research 2013, 6:109-119
Published Date: 20 August 2013